Impact of F-18-Fluorocholine PET/CT and MR Imaging/ Spectroscopy in the Management of Primary and Recurrent Prostate Cancer

Share this content:
Impact of F-18-Fluorocholine PET/CT and MR Imaging/ Spectroscopy in the Management of Primary and Recurrent Prostate Cancer

Sponsor and Collaborators
University of Lausanne Hospitals
Advanced Accelerator Applications
Centre d'Imagerie Biomédicale (CIBM), Lausanne, Switzerland

Contact
John O Prior, PhD MD
+41 21 314 4348
john.prior@chuv.ch

Jean-Yves Meuwly, MD
+41 21 314 4395
jean-yves.meuwly@chuv.ch

Principal Investigator
John O Prior, PhD MD
Centre Hospitalier Universitaire Vaudois

ClinicalTrials.gov Identifier
NCT00963755
You must be a registered member of Renal and Urology News to post a comment.

Sign Up for Free e-newsletters